Concepedia

Lingjuan Zhu

LZ

25

Publications

819

Citations

16

H-Index

2013

Active since

Affiliations

Shenyang Pharmaceutical University(Current)

Jinan University

Sichuan University

State Key Laboratory of Biotherapy

Harbin Medical University

Lingjuan Zhu is an author at Shenyang Pharmaceutical University specializing in medicine, pharmacology, and cell biology.

ORCID

Top concepts

Publications per year

2013–2024

25

Publications

25

Connectivity map identifies luteolin as a treatment option of ischemic stroke by inhibiting MMP9 and activation of the PI3K/Akt signaling pathway

Shijian Luo, Huiqing Li, Zhihuai Mo et al. · Experimental & Molecular Medicine · 2019 · 96 citations · Full text

2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis

Peng Fu, Minru Liao, Wenke Jin et al. · Signal Transduction and Targeted Therapy · 2024 · 91 citations · Full text

Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models

Minru Liao, Qiang Xie, Yuqian Zhao et al. · Pharmacological Research · 2022 · 87 citations

, , +12

Fluoxetine induces autophagic cell death via <scp>eEF</scp>2K‐<scp>AMPK</scp>‐<scp>mTOR</scp>‐<scp>ULK</scp> complex axis in triple negative breast cancer

Dejuan Sun, Lingjuan Zhu, Yuqian Zhao et al. · Cell Proliferation · 2017 · 72 citations · Full text

Eicosapentaenoic acid prevents inflammation induced by acute cerebral infarction through inhibition of NLRP3 inflammasome activation

Zhihuai Mo, Chaogang Tang, Huiqing Li et al. · Life Sciences · 2019 · 64 citations · Full text

Rows per page

1–5 of 25